Asset Management One’s Enanta Pharmaceuticals ENTA Stock Holding History

Asset Management One’s Portfolio ENTA Stock Details ENTA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	–	Sell	-43,575	Closed	-$1.16M	–	1060
2016 Q3	$1.16M	Hold	43,575	–	–	0.02%	794
2016 Q2	$961K	Sell	43,575 -3,527	-7%	-$92.3K	0.01%	852
2016 Q1	$1.38M	Hold	47,102	–	–	0.02%	757
2015 Q4	$1.55M	Hold	47,102	–	–	0.02%	704
2015 Q3	$1.7M	Buy	47,102 +21,494	+84%	+$923K	0.03%	672
2015 Q2	$1.15M	Buy	+25,608	New	+$996K	0.02%	837
2015 Q1	–	Sell	-12,546	Closed	-$647K	–	1350
2014 Q4	$647K	Buy	12,546 +567	+5%	+$25.4K	0.01%	976
2014 Q3	$477K	Sell	11,979 -3,383	-22%	-$135K	0.01%	1029
2014 Q2	$682K	Buy	15,362 +1,862	+14%	+$71K	0.01%	875
2014 Q1	$525K	Buy	13,500 +8,714	+182%	+$317K	0.01%	906
2013 Q4	$134K	Buy	+4,786	New	+$116K	﹤0.01%	1084

Other funds holding ENTA

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

KAM

Krensavage Asset Management New York $256M AUM 69.63% 1-Year Est. Return

GPP

Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

GIM

Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return

First Manhattan New York $36.1B AUM 11.5% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Asset Management One's ENTA Position: Q4 2016 in Review

Asset Management One sold out of Enanta Pharmaceuticals (ENTA) in Q4 2016, closing a stake of 43,575 shares — an estimated $1.16M sold.

Asset Management One first reported a position in ENTA in Q4 2013 and held it in 11 quarters. The position peaked at $1.7M in Q3 2015. 149 funds tracked by Wall St. Rank hold ENTA as of Q4 2016.

Asset Management One reported no remaining Enanta Pharmaceuticals position as of Q4 2016 after selling out during the quarter.
Asset Management One sold 43,575 Enanta Pharmaceuticals shares in Q4 2016, an estimated $1.16M.
Asset Management One first reported a position in Enanta Pharmaceuticals in Q4 2013 and held it in 11 quarters.
Asset Management One's Enanta Pharmaceuticals position peaked at $1.7M in Q3 2015.
149 funds tracked by Wall St. Rank held Enanta Pharmaceuticals as of Q4 2016.

Based on Asset Management One's 13F filing for Q4 2016, filed 13 Feb 2017.